BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9686936)

  • 1. Inhibition of firing rate and changes in the firing pattern of nigral dopamine neurons by gamma-hydroxybutyric acid (GHBA) are specifically induced by activation of GABA(B) receptors.
    Erhardt S; Andersson B; Nissbrandt H; Engberg G
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):611-9. PubMed ID: 9686936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. gamma-Hydroxybutyric acid (GHBA) induces pacemaker activity and inhibition of substantia nigra dopamine neurons by activating GABAB-receptors.
    Engberg G; Nissbrandt H
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Nov; 348(5):491-7. PubMed ID: 8114948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GABAB-receptor activation alters the firing pattern of dopamine neurons in the rat substantia nigra.
    Engberg G; Kling-Petersen T; Nissbrandt H
    Synapse; 1993 Nov; 15(3):229-38. PubMed ID: 8278899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of nigral dopamine neurons by the selective GABA(B)-receptor antagonist SCH 50911.
    Erhardt S; Nissbrandt H; Engberg G
    J Neural Transm (Vienna); 1999; 106(5-6):383-94. PubMed ID: 10443545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GABA(B) receptor-mediated modulation of the firing pattern of ventral tegmental area dopamine neurons in vivo.
    Erhardt S; Mathé JM; Chergui K; Engberg G; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):173-80. PubMed ID: 11882912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologically induced cessation of burst activity in nigral dopamine neurons: significance for the terminal dopamine efflux.
    Nissbrandt H; Elverfors A; Engberg G
    Synapse; 1994 Aug; 17(4):217-24. PubMed ID: 7992197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABA(A) and GABA(B) antagonists differentially affect the firing pattern of substantia nigra dopaminergic neurons in vivo.
    Paladini CA; Tepper JM
    Synapse; 1999 Jun; 32(3):165-76. PubMed ID: 10340627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The GABAB-receptor antagonist, CGP 35348, antagonises gamma-hydroxybutyrate- and baclofen-induced alterations in locomotor activity and forebrain dopamine levels in mice.
    Nissbrandt H; Engberg G
    J Neural Transm (Vienna); 1996; 103(11):1255-63. PubMed ID: 9013412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GABAergic control of rat substantia nigra dopaminergic neurons: role of globus pallidus and substantia nigra pars reticulata.
    Celada P; Paladini CA; Tepper JM
    Neuroscience; 1999 Mar; 89(3):813-25. PubMed ID: 10199615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo.
    Paladini CA; Celada P; Tepper JM
    Neuroscience; 1999 Mar; 89(3):799-812. PubMed ID: 10199614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excitation of nigral dopamine neurons by the GABA(A) receptor agonist muscimol is mediated via release of glutamate.
    Erhardt S; Engberg G
    Life Sci; 2000 Sep; 67(15):1901-11. PubMed ID: 11043612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responses of rat substantia nigra dopamine-containing neurones to (-)-HA-966 in vitro.
    Grobaski KC; Ping H; daSilva HM; Bowery NG; Connelly ST; Shepard PD
    Br J Pharmacol; 1997 Feb; 120(4):575-80. PubMed ID: 9051293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. gamma-Hydroxybutyric acid and baclofen decrease extracellular acetylcholine levels in the hippocampus via GABA(B) receptors.
    Nava F; Carta G; Bortolato M; Gessa GL
    Eur J Pharmacol; 2001 Nov; 430(2-3):261-3. PubMed ID: 11711039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABA(B) receptor activation inhibits dopamine D1 receptor-mediated facilitation of [(3)H]GABA release in substantia nigra pars reticulata.
    Nava-Asbell C; Paz-Bermudez F; Erlij D; Aceves J; Florán B
    Neuropharmacology; 2007 Oct; 53(5):631-7. PubMed ID: 17868750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma-hydroxybutyric acid decreases thalamic sensory excitatory postsynaptic potentials by an action on presynaptic GABAB receptors.
    Emri Z; Antal K; Crunelli V
    Neurosci Lett; 1996 Sep; 216(2):121-4. PubMed ID: 8904798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminative stimulus effects of gamma-hydroxybutyrate (GHB) in rats discriminating GHB from baclofen and diazepam.
    Koek W; Carter LP; Lamb RJ; Chen W; Wu H; Coop A; France CP
    J Pharmacol Exp Ther; 2005 Jul; 314(1):170-9. PubMed ID: 15774716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of dopamine re-uptake: significance for nigral dopamine neuron activity.
    Engberg G; Elverfors A; Jonason J; Nissbrandt H
    Synapse; 1997 Feb; 25(2):215-26. PubMed ID: 9021902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indirect presynaptic modulation of striatal dopamine release by GABA(B) receptors in the rat substantia nigra.
    Balon N; Kriem B; Weiss M; Rostain JC
    Neurosci Lett; 2002 May; 325(1):33-6. PubMed ID: 12023061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of sodium gamma-hydroxybutyrate on GABA receptors and catecholamine effect potentiation.
    Kozhechkin SN
    Arch Int Pharmacodyn Ther; 1981 Apr; 250(2):242-53. PubMed ID: 6268008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anaesthetic agent propofol interacts with GABA(B)-receptors: an electrophysiological study in rat.
    Schwieler L; Delbro DS; Engberg G; Erhardt S
    Life Sci; 2003 May; 72(24):2793-801. PubMed ID: 12679195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.